Stock Research: Convatec Group

Independent, rules-based stock research to judge this stock's true performance: Cut through market noise and find high-growth or high-value gems from 8,000+ stocks worldwide.

Convatec Group

LSE:CTEC GB00BD3VFW73
40
  • Value
    47
  • Growth
    36
  • Safety
    Safety
    18
  • Combined
    16
  • Sentiment
    92
  • 360° View
    360° View
    40
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Convatec Group Plc is a medical products and technologies company. It operates in the medical products and technologies industry, with a focus on solutions for chronic conditions, including Advanced Wound Care, Ostomy Care, Continence Care, and Infusion Care. The company markets and sells its solutions and services globally. In the last fiscal year, the company had a market cap of $6,659 million, profits of $1,299 million, and revenue of $2,289 million with 10,483 employees.

more
Index
FTSE All Shares
FTSE 100
FTSE 350
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 2-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
47 60 53 87
Growth
36 10 29 7
Safety
Safety
18 19 8 39
Sentiment
92 80 85 66
360° View
360° View
40 32 30 51
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
81 75 82 38
Opinions Change
46 53 46 50
Pro Holdings
n/a 92 54 90
Market Pulse
69 51 74 40
Sentiment
92 80 85 66
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
47 60 53 87
Growth
36 10 29 7
Safety Safety
18 19 8 39
Combined
16 1 10 33
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
36 49 48 78
Price vs. Earnings (P/E)
56 56 50 78
Price vs. Book (P/B)
22 22 16 73
Dividend Yield
68 75 74 65
Value
47 60 53 87
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
34 4 26 17
Profit Growth
60 45 52 16
Capital Growth
17 25 16 34
Stock Returns
57 54 65 25
Growth
36 10 29 7
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
31 23 26 18
Refinancing
38 34 23 69
Liquidity
30 32 28 33
Safety Safety
18 19 8 39

Similar Stocks

Discover high‑ranked alternatives to Convatec Group and broaden your portfolio horizons.

Drägerwerk

GER:DRW8
Country: Germany
Industry: Health Care Equipment
Size: Medium
Full Stock Analysis

Metlen Energy & Metals

LSE:MTLN
Country: United Kingdom
Industry: Industrial Conglomerates
Size: Large
Full Stock Analysis

Vodafone

LSE:VOD
Country: United Kingdom
Industry: Wireless Telecommunication
Size: XX-Large
Full Stock Analysis

Smith & Nephew

LSE:SN.
Country: United Kingdom
Industry: Health Care Equipment
Size: Large
Full Stock Analysis

Frequently Asked
Questions

With good value and positive sentiment, but low growth and risky financing, this combination is generally dangerous as debt requires growth to sustain it. Only investors with a strong belief in future growth potential and a high-risk tolerance should consider this stock.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing: